Cosmetics & Personal Care | Monthly bulletin | August 2021
Eurofins collaborates on an article discussing a multicenter study management of a Class III medical device
In collaboration with renowned medical teams, Eurofins Pharmascan, part of Eurofins Cosmetics & Personal Care, can conduct studies either on our own sites (CRC activity) and/or in medical offices (CRO activity).
In a paper recently published in Dermatologic Surgery1, authors acknowledged Eurofins Pharmascan members for their input in the study management on a clinical study of a Class III medical device. It was a European multicenter study with the aim to demonstrate the long-term safety and effectiveness of a polycaprolactone based dermal filler in nasolabial fold correction. Acting as a CRO, Eurofins Pharmascan managed all the study phases, from the requirement of regulatory authorizations through to the study realization and monitoring with a dedicated expert team; it ensured the data management and statistical analysis up to the clinical study report (CSR).
Contact us for the management of your medical devices’ projects, we offer a complete support.
1Moers-Carpi M, Christen MO, Delmar H, Brun P, Bodokh I, Kestemont P. European Multicenter Prospective Study Evaluating Long-Term Safety and Efficacy of the Polycaprolactone-Based Dermal Filler in Nasolabial Fold Correction. Dermatologic Surgery 2021; 47 (7): 960-965 >> Link
Eurofins Cosmetics & Personal Care to sponsor and exhibit at the 2021 FLSCC Sunscreen Symposium
Eurofins Cosmetics & Personal Care is excited to announce we will be sponsoring and exhibiting at this year’s FLSCC Sunscreen Symposium, Predicting The Future: Sun Care Trends In An Uncertain Regulatory Environment. The event is taking place between September 23rd and September 25th at the Disney Yacht & Beach Club Resort, Florida. Come and see us at Booth #37.
Eurofins Cosmetics & Personal Care provides a broad range of testing services for all types of sunscreen products. We are leaders in SPF testing, having 17 sun care testing laboratories worldwide, including Australia, Europe, US, and China. With a team of experts actively involved in standardization committees, Eurofins is committed to staying abreast to the current and future regulatory sun care testing environment.
Click here for more information about the event or contact us today. We hope to see you there and discuss all your sun care needs.
Allergens in Cosmetics, a challenge for the entire Cosmetics & Personal Care industry
More than 2´500 fragrance ingredients are used in perfumes and perfumed consumer goods such as cosmetics, detergents, fabric softeners and other household products to give them a specific, usually pleasant smell. These ingredients can sometimes cause skin irritation or allergic reactions.
Cosmetics Regulation (EC) No. 1223/2009 (Article 19 in conjunction with Annex III) identifies 26 allergens, derived from synthetic fragrances, as well as natural essential oils and extracts as restricted ingredients. In practice, this means that if a given allergen exceeds 0.01% in a rinse-off cosmetic (e.g. soap, shower gel, shampoo) or 0.001% in a leave-on cosmetic (e.g. cream, lotion, tonic) then it must be listed on a cosmetic product label as part of the INCI composition for consumer information.
The Scientific Committee on Consumer Safety (SCCS) in its opinion on fragrance allergens in cosmetic products (SCCS/1449/11) stated that consumers should also be informed about an additional 28 fragrance ingredients that has been established as contact allergens in humans in addition to the current list of 26 allergens.
Eurofins offers our customers an overview of all critical allergens in one fell swoop with state-of-the art GC-MSD analysis on the basis of the latest edition of the norm EN 16274 (Methods for analysis of allergens – Quantification of suspected fragrance allergens in consumer products- GC analysis of ready-to-inject sample). You can benefit from our many years of analytical competence and a Europe-wide comparability of your products using the CEN Method.
